

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nucleotide salvage (GO:0043173) | 9.22377700 |
| 2 | pyrimidine nucleoside salvage (GO:0043097) | 9.10906959 |
| 3 | pyrimidine-containing compound salvage (GO:0008655) | 9.10906959 |
| 4 | nucleoside salvage (GO:0043174) | 8.75282133 |
| 5 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 7.74333978 |
| 6 | UMP metabolic process (GO:0046049) | 7.74333978 |
| 7 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 7.74333978 |
| 8 | UMP biosynthetic process (GO:0006222) | 7.74333978 |
| 9 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 6.84681002 |
| 10 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 6.40978985 |
| 11 | pentose metabolic process (GO:0019321) | 5.41089491 |
| 12 | CTP metabolic process (GO:0046036) | 5.16825908 |
| 13 | CTP biosynthetic process (GO:0006241) | 5.16825908 |
| 14 | diterpenoid biosynthetic process (GO:0016102) | 5.02067678 |
| 15 | purine nucleotide salvage (GO:0032261) | 4.98636694 |
| 16 | pentose-phosphate shunt (GO:0006098) | 4.80620574 |
| 17 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 4.78794425 |
| 18 | positive regulation of antigen processing and presentation (GO:0002579) | 4.77440521 |
| 19 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 4.62730092 |
| 20 | AMP metabolic process (GO:0046033) | 4.58341753 |
| 21 | DNA deamination (GO:0045006) | 4.46527383 |
| 22 | immunoglobulin mediated immune response (GO:0016064) | 4.38876358 |
| 23 | regulation of antigen processing and presentation (GO:0002577) | 4.37894165 |
| 24 | cellular metabolic compound salvage (GO:0043094) | 4.29674315 |
| 25 | keratinocyte development (GO:0003334) | 4.25576239 |
| 26 | activation of NF-kappaB-inducing kinase activity (GO:0007250) | 4.23693650 |
| 27 | regulation of activation of Janus kinase activity (GO:0010533) | 4.18633162 |
| 28 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 4.16768447 |
| 29 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 4.14213991 |
| 30 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.13235777 |
| 31 | NADPH regeneration (GO:0006740) | 4.12653443 |
| 32 | response to folic acid (GO:0051593) | 4.10786531 |
| 33 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.98590730 |
| 34 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.98300012 |
| 35 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.98300012 |
| 36 | negative regulation of JAK-STAT cascade (GO:0046426) | 3.94782229 |
| 37 | negative thymic T cell selection (GO:0045060) | 3.83755656 |
| 38 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.81347063 |
| 39 | DNA dealkylation (GO:0035510) | 3.80621942 |
| 40 | positive thymic T cell selection (GO:0045059) | 3.70195142 |
| 41 | response to interferon-beta (GO:0035456) | 3.69033778 |
| 42 | negative T cell selection (GO:0043383) | 3.62349556 |
| 43 | pyrimidine ribonucleoside biosynthetic process (GO:0046132) | 3.61727997 |
| 44 | glucose catabolic process (GO:0006007) | 3.61063189 |
| 45 | terpenoid biosynthetic process (GO:0016114) | 3.53346989 |
| 46 | pyrimidine ribonucleoside metabolic process (GO:0046131) | 3.44144416 |
| 47 | B cell mediated immunity (GO:0019724) | 3.40306091 |
| 48 | regulation of hypersensitivity (GO:0002883) | 3.40208952 |
| 49 | DNA ligation (GO:0006266) | 3.39872846 |
| 50 | pyrimidine ribonucleotide biosynthetic process (GO:0009220) | 3.38444801 |
| 51 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.37089863 |
| 52 | neutrophil activation involved in immune response (GO:0002283) | 3.34655943 |
| 53 | pyrimidine ribonucleotide metabolic process (GO:0009218) | 3.33214338 |
| 54 | cellular response to interferon-beta (GO:0035458) | 3.32748212 |
| 55 | positive regulation of NIK/NF-kappaB signaling (GO:1901224) | 3.30915277 |
| 56 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.29107310 |
| 57 | translational elongation (GO:0006414) | 3.28061006 |
| 58 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.26928732 |
| 59 | grooming behavior (GO:0007625) | 3.23743239 |
| 60 | viral transcription (GO:0019083) | 3.17575011 |
| 61 | T cell costimulation (GO:0031295) | 3.16653141 |
| 62 | cytidine metabolic process (GO:0046087) | 3.12840266 |
| 63 | cytidine catabolic process (GO:0006216) | 3.12840266 |
| 64 | cytidine deamination (GO:0009972) | 3.12840266 |
| 65 | lymphocyte costimulation (GO:0031294) | 3.12764700 |
| 66 | retinal metabolic process (GO:0042574) | 3.12755024 |
| 67 | thymic T cell selection (GO:0045061) | 3.08369236 |
| 68 | translational termination (GO:0006415) | 3.04568744 |
| 69 | cardiolipin metabolic process (GO:0032048) | 2.99515625 |
| 70 | negative regulation of B cell apoptotic process (GO:0002903) | 2.99349996 |
| 71 | neutrophil mediated immunity (GO:0002446) | 2.98220121 |
| 72 | mammary gland epithelial cell differentiation (GO:0060644) | 2.96886782 |
| 73 | cellular response to interferon-gamma (GO:0071346) | 2.96426478 |
| 74 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.95029412 |
| 75 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.94935520 |
| 76 | pyrimidine nucleoside biosynthetic process (GO:0046134) | 2.86946288 |
| 77 | negative regulation of interleukin-8 production (GO:0032717) | 2.79662689 |
| 78 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.79606936 |
| 79 | pyrimidine nucleotide biosynthetic process (GO:0006221) | 2.79526059 |
| 80 | ribosomal small subunit assembly (GO:0000028) | 2.77006670 |
| 81 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.76284787 |
| 82 | regulation of NIK/NF-kappaB signaling (GO:1901222) | 2.75642386 |
| 83 | L-methionine salvage (GO:0071267) | 2.75467608 |
| 84 | L-methionine biosynthetic process (GO:0071265) | 2.75467608 |
| 85 | amino acid salvage (GO:0043102) | 2.75467608 |
| 86 | T cell selection (GO:0045058) | 2.68443095 |
| 87 | positive regulation of prostaglandin secretion (GO:0032308) | 2.68418972 |
| 88 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.67161857 |
| 89 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.66637942 |
| 90 | positive T cell selection (GO:0043368) | 2.66070604 |
| 91 | response to interferon-gamma (GO:0034341) | 2.64079868 |
| 92 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.63993577 |
| 93 | response to nitric oxide (GO:0071731) | 2.63581115 |
| 94 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.62281774 |
| 95 | positive regulation of neutrophil migration (GO:1902624) | 2.62281774 |
| 96 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.61904920 |
| 97 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.59943512 |
| 98 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.58298886 |
| 99 | cytokine biosynthetic process (GO:0042089) | 2.58208243 |
| 100 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.57804662 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.86482804 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.74525746 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.85870970 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.26153028 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.70471796 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.65746353 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.46648228 |
| 8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.42211281 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.35864908 |
| 10 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.22115974 |
| 11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.01677104 |
| 12 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.01584929 |
| 13 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00176556 |
| 14 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.98519398 |
| 15 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.95113013 |
| 16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.92113368 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89551577 |
| 18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.86761207 |
| 19 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.82399986 |
| 20 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.82290166 |
| 21 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.78600829 |
| 22 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.74159741 |
| 23 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.74139932 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 1.73219394 |
| 25 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.72798895 |
| 26 | GATA3_26560356_Chip-Seq_TH2_Human | 1.70026396 |
| 27 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67796445 |
| 28 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.64134688 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.62744949 |
| 30 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.60887411 |
| 31 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.52753165 |
| 32 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.49030904 |
| 33 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.47563150 |
| 34 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.43886561 |
| 35 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.40703296 |
| 36 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.39271239 |
| 37 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.38269558 |
| 38 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.36402955 |
| 39 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.35860961 |
| 40 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.34716679 |
| 41 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.34688756 |
| 42 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.32924663 |
| 43 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.31788929 |
| 44 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.31206040 |
| 45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.28860956 |
| 46 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.27922084 |
| 47 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.26845967 |
| 48 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.26525548 |
| 49 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.25874712 |
| 50 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.25266079 |
| 51 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.23401738 |
| 52 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.22956872 |
| 53 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.22814145 |
| 54 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.21995111 |
| 55 | AR_20517297_ChIP-Seq_VCAP_Human | 1.21548313 |
| 56 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.20735678 |
| 57 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.20277752 |
| 58 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.19861324 |
| 59 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.19426784 |
| 60 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.18553601 |
| 61 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.17098728 |
| 62 | MYB_26560356_Chip-Seq_TH1_Human | 1.16097190 |
| 63 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.15458147 |
| 64 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.15414859 |
| 65 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.14565778 |
| 66 | MAF_26560356_Chip-Seq_TH1_Human | 1.14510247 |
| 67 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.14022041 |
| 68 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.11877863 |
| 69 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.11330227 |
| 70 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.10651968 |
| 71 | P68_20966046_ChIP-Seq_HELA_Human | 1.10513795 |
| 72 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.10042596 |
| 73 | ERA_21632823_ChIP-Seq_H3396_Human | 1.07682575 |
| 74 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04620781 |
| 75 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.04336093 |
| 76 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.03424901 |
| 77 | P300_27268052_Chip-Seq_Bcells_Human | 1.02824715 |
| 78 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.02465597 |
| 79 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.02234906 |
| 80 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.99110091 |
| 81 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99058953 |
| 82 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98335190 |
| 83 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.97831792 |
| 84 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.97029767 |
| 85 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95737026 |
| 86 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.94867912 |
| 87 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93527069 |
| 88 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.93525984 |
| 89 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.92156525 |
| 90 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.90112769 |
| 91 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.89851359 |
| 92 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87728114 |
| 93 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.87404822 |
| 94 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.87170116 |
| 95 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87095760 |
| 96 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87062014 |
| 97 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.86602526 |
| 98 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.86278587 |
| 99 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.86271433 |
| 100 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.85401210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.21050489 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.67724058 |
| 3 | MP0003646_muscle_fatigue | 3.46500467 |
| 4 | MP0005000_abnormal_immune_tolerance | 2.99151042 |
| 5 | MP0001873_stomach_inflammation | 2.91379730 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 2.86760403 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 2.82486402 |
| 8 | MP0005671_abnormal_response_to | 2.77697459 |
| 9 | MP0002163_abnormal_gland_morphology | 2.71683421 |
| 10 | MP0006082_CNS_inflammation | 2.70694576 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.65215275 |
| 12 | MP0005360_urolithiasis | 2.40511847 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.29711739 |
| 14 | MP0001800_abnormal_humoral_immune | 2.17377948 |
| 15 | MP0005387_immune_system_phenotype | 2.16344004 |
| 16 | MP0001790_abnormal_immune_system | 2.16344004 |
| 17 | MP0004145_abnormal_muscle_electrophysio | 2.14261487 |
| 18 | MP0002723_abnormal_immune_serum | 2.03454520 |
| 19 | MP0001346_abnormal_lacrimal_gland | 2.01422049 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.01388952 |
| 21 | MP0009785_altered_susceptibility_to | 1.99360753 |
| 22 | MP0005165_increased_susceptibility_to | 1.94900398 |
| 23 | MP0003436_decreased_susceptibility_to | 1.87360689 |
| 24 | MP0010155_abnormal_intestine_physiology | 1.86881492 |
| 25 | MP0002420_abnormal_adaptive_immunity | 1.86782372 |
| 26 | MP0001819_abnormal_immune_cell | 1.83998061 |
| 27 | MP0005167_abnormal_blood-brain_barrier | 1.81011777 |
| 28 | MP0005025_abnormal_response_to | 1.79400470 |
| 29 | MP0005075_abnormal_melanosome_morpholog | 1.77925985 |
| 30 | MP0000685_abnormal_immune_system | 1.77098219 |
| 31 | MP0002234_abnormal_pharynx_morphology | 1.76719145 |
| 32 | MP0005646_abnormal_pituitary_gland | 1.76151635 |
| 33 | MP0008872_abnormal_physiological_respon | 1.62508272 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.56647916 |
| 35 | MP0000538_abnormal_urinary_bladder | 1.53763632 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.52215871 |
| 37 | MP0002419_abnormal_innate_immunity | 1.47648213 |
| 38 | MP0009764_decreased_sensitivity_to | 1.46811200 |
| 39 | MP0003763_abnormal_thymus_physiology | 1.46086584 |
| 40 | MP0002102_abnormal_ear_morphology | 1.44080574 |
| 41 | MP0001853_heart_inflammation | 1.44026918 |
| 42 | MP0003866_abnormal_defecation | 1.43541484 |
| 43 | MP0005379_endocrine/exocrine_gland_phen | 1.39864273 |
| 44 | MP0000716_abnormal_immune_system | 1.39664112 |
| 45 | MP0006292_abnormal_olfactory_placode | 1.37978301 |
| 46 | MP0004036_abnormal_muscle_relaxation | 1.37005030 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.32332690 |
| 48 | MP0002398_abnormal_bone_marrow | 1.29626537 |
| 49 | MP0000689_abnormal_spleen_morphology | 1.28345164 |
| 50 | MP0008775_abnormal_heart_ventricle | 1.25663302 |
| 51 | MP0003075_altered_response_to | 1.21158645 |
| 52 | MP0002933_joint_inflammation | 1.20384767 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.19233577 |
| 54 | MP0002876_abnormal_thyroid_physiology | 1.18251657 |
| 55 | MP0002429_abnormal_blood_cell | 1.17534257 |
| 56 | MP0002166_altered_tumor_susceptibility | 1.17102735 |
| 57 | MP0001756_abnormal_urination | 1.16612206 |
| 58 | MP0002837_dystrophic_cardiac_calcinosis | 1.16584188 |
| 59 | MP0001663_abnormal_digestive_system | 1.16459850 |
| 60 | MP0002277_abnormal_respiratory_mucosa | 1.15875180 |
| 61 | MP0008873_increased_physiological_sensi | 1.15322420 |
| 62 | MP0002722_abnormal_immune_system | 1.13743355 |
| 63 | MP0009278_abnormal_bone_marrow | 1.11753959 |
| 64 | MP0001348_abnormal_lacrimal_gland | 1.08874158 |
| 65 | MP0000372_irregular_coat_pigmentation | 1.05638242 |
| 66 | MP0001545_abnormal_hematopoietic_system | 1.04891502 |
| 67 | MP0005397_hematopoietic_system_phenotyp | 1.04891502 |
| 68 | MP0005310_abnormal_salivary_gland | 1.02255350 |
| 69 | MP0001664_abnormal_digestion | 1.00811554 |
| 70 | MP0000613_abnormal_salivary_gland | 1.00102243 |
| 71 | MP0004147_increased_porphyrin_level | 0.98394495 |
| 72 | MP0002006_tumorigenesis | 0.98194843 |
| 73 | MP0008469_abnormal_protein_level | 0.96802629 |
| 74 | MP0005166_decreased_susceptibility_to | 0.90192362 |
| 75 | MP0000681_abnormal_thyroid_gland | 0.90032033 |
| 76 | MP0002405_respiratory_system_inflammati | 0.88605106 |
| 77 | MP0000383_abnormal_hair_follicle | 0.86282289 |
| 78 | MP0004782_abnormal_surfactant_physiolog | 0.85736394 |
| 79 | MP0009763_increased_sensitivity_to | 0.84831056 |
| 80 | MP0005451_abnormal_body_composition | 0.83365075 |
| 81 | MP0000858_altered_metastatic_potential | 0.81227926 |
| 82 | MP0009643_abnormal_urine_homeostasis | 0.80955698 |
| 83 | MP0001968_abnormal_touch/_nociception | 0.80309002 |
| 84 | MP0003191_abnormal_cellular_cholesterol | 0.79634360 |
| 85 | MP0002693_abnormal_pancreas_physiology | 0.77617159 |
| 86 | MP0000703_abnormal_thymus_morphology | 0.75228615 |
| 87 | MP0003279_aneurysm | 0.74907411 |
| 88 | MP0000343_altered_response_to | 0.74747475 |
| 89 | MP0004885_abnormal_endolymph | 0.73164955 |
| 90 | MP0000230_abnormal_systemic_arterial | 0.72192076 |
| 91 | MP0000467_abnormal_esophagus_morphology | 0.71798987 |
| 92 | MP0001905_abnormal_dopamine_level | 0.71381635 |
| 93 | MP0005332_abnormal_amino_acid | 0.70683496 |
| 94 | MP0004947_skin_inflammation | 0.70505877 |
| 95 | MP0002139_abnormal_hepatobiliary_system | 0.68855294 |
| 96 | MP0005381_digestive/alimentary_phenotyp | 0.68582485 |
| 97 | MP0006036_abnormal_mitochondrial_physio | 0.65278632 |
| 98 | MP0002736_abnormal_nociception_after | 0.64041827 |
| 99 | MP0003638_abnormal_response/metabolism_ | 0.63472659 |
| 100 | MP0002932_abnormal_joint_morphology | 0.63248485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoplasia of the pons (HP:0012110) | 4.60523989 |
| 2 | Difficulty running (HP:0009046) | 4.42133921 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.18301146 |
| 4 | Abnormality of the pons (HP:0007361) | 4.15817667 |
| 5 | Opisthotonus (HP:0002179) | 4.13209095 |
| 6 | Achilles tendon contracture (HP:0001771) | 3.69967695 |
| 7 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.48006378 |
| 8 | Abnormality of the periventricular white matter (HP:0002518) | 3.41143606 |
| 9 | Increased hepatocellular lipid droplets (HP:0006565) | 3.38895148 |
| 10 | Hip dysplasia (HP:0001385) | 3.38609662 |
| 11 | Abnormality of the prostate (HP:0008775) | 3.33788208 |
| 12 | Abnormality of the Achilles tendon (HP:0005109) | 3.31685819 |
| 13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.16196909 |
| 14 | Increased intramyocellular lipid droplets (HP:0012240) | 3.14279933 |
| 15 | Panhypogammaglobulinemia (HP:0003139) | 3.12561492 |
| 16 | Congenital, generalized hypertrichosis (HP:0004540) | 3.05853044 |
| 17 | Decreased central vision (HP:0007663) | 3.03809683 |
| 18 | Lipid accumulation in hepatocytes (HP:0006561) | 2.96045736 |
| 19 | Exertional dyspnea (HP:0002875) | 2.95088340 |
| 20 | Hip contracture (HP:0003273) | 2.88370037 |
| 21 | Degeneration of anterior horn cells (HP:0002398) | 2.76213505 |
| 22 | Abnormality of the anterior horn cell (HP:0006802) | 2.76213505 |
| 23 | Mediastinal lymphadenopathy (HP:0100721) | 2.76045075 |
| 24 | Autoimmune thrombocytopenia (HP:0001973) | 2.74709197 |
| 25 | Progressive microcephaly (HP:0000253) | 2.73729171 |
| 26 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.64433405 |
| 27 | Increased muscle lipid content (HP:0009058) | 2.63648995 |
| 28 | Mitochondrial inheritance (HP:0001427) | 2.61282559 |
| 29 | Pustule (HP:0200039) | 2.48012085 |
| 30 | Microvesicular hepatic steatosis (HP:0001414) | 2.45364237 |
| 31 | Visual hallucinations (HP:0002367) | 2.44385398 |
| 32 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.40275306 |
| 33 | Abnormal number of erythroid precursors (HP:0012131) | 2.38477710 |
| 34 | Renal Fanconi syndrome (HP:0001994) | 2.36307371 |
| 35 | Agammaglobulinemia (HP:0004432) | 2.36110999 |
| 36 | 3-Methylglutaconic aciduria (HP:0003535) | 2.35516191 |
| 37 | Meningitis (HP:0001287) | 2.32121682 |
| 38 | Abnormality of T cell physiology (HP:0011840) | 2.24438696 |
| 39 | Ulnar deviation of the wrist (HP:0003049) | 2.20626571 |
| 40 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.20308176 |
| 41 | Abnormality of B cell number (HP:0010975) | 2.18606173 |
| 42 | Eosinophilia (HP:0001880) | 2.17695455 |
| 43 | IgG deficiency (HP:0004315) | 2.15181021 |
| 44 | Hypoplasia of the uterus (HP:0000013) | 2.15167231 |
| 45 | Limited hip movement (HP:0008800) | 2.14173213 |
| 46 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.13901571 |
| 47 | Carpal bone hypoplasia (HP:0001498) | 2.13227957 |
| 48 | Pulmonary infiltrates (HP:0002113) | 2.12059712 |
| 49 | Impaired smooth pursuit (HP:0007772) | 2.11907546 |
| 50 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.10692073 |
| 51 | Vasculitis (HP:0002633) | 2.09550516 |
| 52 | Increased corneal curvature (HP:0100692) | 2.08922650 |
| 53 | Keratoconus (HP:0000563) | 2.08922650 |
| 54 | Increased CSF lactate (HP:0002490) | 2.08569533 |
| 55 | Pancreatic cysts (HP:0001737) | 2.08265178 |
| 56 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.05648007 |
| 57 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.05467597 |
| 58 | Prostate neoplasm (HP:0100787) | 2.03365820 |
| 59 | Fasciculations (HP:0002380) | 2.03175166 |
| 60 | Hepatocellular necrosis (HP:0001404) | 2.02217869 |
| 61 | Acute necrotizing encephalopathy (HP:0006965) | 2.01514151 |
| 62 | Pancreatic fibrosis (HP:0100732) | 2.01056539 |
| 63 | Abnormality of T cells (HP:0002843) | 2.00303508 |
| 64 | Pulmonary fibrosis (HP:0002206) | 1.99482352 |
| 65 | Myositis (HP:0100614) | 1.96951827 |
| 66 | Hyperglycinemia (HP:0002154) | 1.96500511 |
| 67 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.96116119 |
| 68 | Esophageal neoplasm (HP:0100751) | 1.95597482 |
| 69 | Neoplasm of head and neck (HP:0012288) | 1.95597482 |
| 70 | Increased serum ferritin (HP:0003281) | 1.92474562 |
| 71 | Spondylolisthesis (HP:0003302) | 1.92324767 |
| 72 | Hypoproteinemia (HP:0003075) | 1.91460592 |
| 73 | Granulocytopenia (HP:0001913) | 1.90546412 |
| 74 | Chest pain (HP:0100749) | 1.89311674 |
| 75 | Short femoral neck (HP:0100864) | 1.89200766 |
| 76 | Delayed epiphyseal ossification (HP:0002663) | 1.86677676 |
| 77 | Prolonged neonatal jaundice (HP:0006579) | 1.86238570 |
| 78 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.86119760 |
| 79 | IgM deficiency (HP:0002850) | 1.84776392 |
| 80 | Restlessness (HP:0000711) | 1.83838270 |
| 81 | Poor eye contact (HP:0000817) | 1.83664283 |
| 82 | Periorbital edema (HP:0100539) | 1.80833884 |
| 83 | Facial edema (HP:0000282) | 1.80483685 |
| 84 | Asplenia (HP:0001746) | 1.80475967 |
| 85 | Bile duct proliferation (HP:0001408) | 1.79918031 |
| 86 | Abnormal biliary tract physiology (HP:0012439) | 1.79918031 |
| 87 | Parakeratosis (HP:0001036) | 1.79848406 |
| 88 | Stomach cancer (HP:0012126) | 1.79500966 |
| 89 | Hepatic necrosis (HP:0002605) | 1.78737920 |
| 90 | Dyskinesia (HP:0100660) | 1.78491849 |
| 91 | Small epiphyses (HP:0010585) | 1.76739987 |
| 92 | Autoimmune hemolytic anemia (HP:0001890) | 1.75778635 |
| 93 | Increased serum lactate (HP:0002151) | 1.75730478 |
| 94 | Molar tooth sign on MRI (HP:0002419) | 1.74724300 |
| 95 | Abnormality of midbrain morphology (HP:0002418) | 1.74724300 |
| 96 | Abnormality of male internal genitalia (HP:0000022) | 1.74562297 |
| 97 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.74398908 |
| 98 | Lactic acidosis (HP:0003128) | 1.73139944 |
| 99 | Absent phalangeal crease (HP:0006109) | 1.72126186 |
| 100 | Abnormality of the pleura (HP:0002103) | 1.71118493 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LIMK1 | 4.71731944 |
| 2 | MAP4K1 | 4.16895957 |
| 3 | TAOK3 | 3.43834490 |
| 4 | TLK1 | 3.11586347 |
| 5 | TIE1 | 3.10778948 |
| 6 | TXK | 3.04248744 |
| 7 | KDR | 2.87094502 |
| 8 | TESK1 | 2.62640012 |
| 9 | ZAK | 2.50460228 |
| 10 | VRK2 | 2.45561115 |
| 11 | BCKDK | 2.25544657 |
| 12 | KIT | 2.23674502 |
| 13 | CSF1R | 2.19872018 |
| 14 | IKBKE | 1.93400778 |
| 15 | JAK3 | 1.81092207 |
| 16 | NME2 | 1.79501945 |
| 17 | ADRBK2 | 1.77167159 |
| 18 | PHKG2 | 1.71690402 |
| 19 | PHKG1 | 1.71690402 |
| 20 | MAPKAPK3 | 1.68100584 |
| 21 | TBK1 | 1.65705983 |
| 22 | TEC | 1.56690693 |
| 23 | SYK | 1.55881804 |
| 24 | GRK1 | 1.52999471 |
| 25 | IKBKB | 1.51478863 |
| 26 | ITK | 1.41739142 |
| 27 | TESK2 | 1.32473666 |
| 28 | VRK1 | 1.29168730 |
| 29 | RPS6KA5 | 1.28806744 |
| 30 | CSNK1G1 | 1.28271625 |
| 31 | LYN | 1.23042266 |
| 32 | MST4 | 1.21695533 |
| 33 | MUSK | 1.21264813 |
| 34 | BMPR1B | 1.10791933 |
| 35 | CCNB1 | 1.08134193 |
| 36 | GRK7 | 1.06797751 |
| 37 | LCK | 1.04906484 |
| 38 | PIK3CG | 1.02693858 |
| 39 | MYLK | 0.96113547 |
| 40 | ARAF | 0.94647354 |
| 41 | CDK8 | 0.94392132 |
| 42 | MAP3K14 | 0.89157135 |
| 43 | PKN1 | 0.87690767 |
| 44 | OBSCN | 0.86500764 |
| 45 | BLK | 0.86230676 |
| 46 | DAPK1 | 0.85862140 |
| 47 | PRKCQ | 0.83711216 |
| 48 | PIM2 | 0.82188775 |
| 49 | FES | 0.81581246 |
| 50 | NLK | 0.81070582 |
| 51 | GRK6 | 0.79418279 |
| 52 | FRK | 0.76552835 |
| 53 | MAPKAPK5 | 0.76026542 |
| 54 | BTK | 0.75821653 |
| 55 | RIPK4 | 0.72343076 |
| 56 | CSNK1G3 | 0.72040252 |
| 57 | MATK | 0.70443311 |
| 58 | INSRR | 0.70174853 |
| 59 | MAP2K6 | 0.70102271 |
| 60 | TRPM7 | 0.69383580 |
| 61 | ADRBK1 | 0.65486128 |
| 62 | PLK2 | 0.63067473 |
| 63 | PDK1 | 0.62765215 |
| 64 | CSK | 0.60210814 |
| 65 | ABL1 | 0.59134391 |
| 66 | PAK1 | 0.58863724 |
| 67 | FLT3 | 0.54340226 |
| 68 | GRK5 | 0.54254946 |
| 69 | IGF1R | 0.53267905 |
| 70 | DYRK1A | 0.48627855 |
| 71 | EPHA2 | 0.47746959 |
| 72 | PRKCA | 0.46815530 |
| 73 | CSNK2A1 | 0.45937869 |
| 74 | DAPK3 | 0.45257901 |
| 75 | ILK | 0.44018995 |
| 76 | OXSR1 | 0.43892343 |
| 77 | MAP2K7 | 0.42887353 |
| 78 | MAP4K2 | 0.41887287 |
| 79 | CDK4 | 0.41492322 |
| 80 | PRKCI | 0.41234943 |
| 81 | CSNK1A1 | 0.40802551 |
| 82 | IRAK3 | 0.40634854 |
| 83 | IRAK4 | 0.39829870 |
| 84 | CSNK1A1L | 0.38729716 |
| 85 | CSNK2A2 | 0.37000475 |
| 86 | LMTK2 | 0.36521867 |
| 87 | CSNK1G2 | 0.36051068 |
| 88 | MAPKAPK2 | 0.35884835 |
| 89 | HCK | 0.34970729 |
| 90 | CDC42BPA | 0.34274462 |
| 91 | DAPK2 | 0.33248187 |
| 92 | FYN | 0.32497619 |
| 93 | EGFR | 0.32344800 |
| 94 | MAPK3 | 0.31642245 |
| 95 | MOS | 0.31612357 |
| 96 | NUAK1 | 0.28587177 |
| 97 | CAMKK1 | 0.25960453 |
| 98 | AURKA | 0.25492318 |
| 99 | TGFBR2 | 0.25326646 |
| 100 | TGFBR1 | 0.24195617 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 4.95462387 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 4.75918592 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.52311595 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.47630779 |
| 5 | Sulfur relay system_Homo sapiens_hsa04122 | 3.93830709 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.86007672 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.82034846 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.77684565 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.52608606 |
| 10 | Viral myocarditis_Homo sapiens_hsa05416 | 2.45458133 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.34565503 |
| 12 | Ribosome_Homo sapiens_hsa03010 | 2.32381440 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 2.25788974 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.09415392 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.98461788 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.92098202 |
| 17 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.91099740 |
| 18 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.82706236 |
| 19 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.65587638 |
| 20 | Proteasome_Homo sapiens_hsa03050 | 1.64876933 |
| 21 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.30650616 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.25750882 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.25561615 |
| 24 | DNA replication_Homo sapiens_hsa03030 | 1.09808595 |
| 25 | Phototransduction_Homo sapiens_hsa04744 | 1.09220276 |
| 26 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.08891137 |
| 27 | Measles_Homo sapiens_hsa05162 | 1.02395197 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.97356996 |
| 29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.94987868 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.93840646 |
| 31 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.93838610 |
| 32 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.93337695 |
| 33 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.92438389 |
| 34 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.90193785 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 0.88223007 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.82892431 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.81310488 |
| 38 | Parkinsons disease_Homo sapiens_hsa05012 | 0.78917003 |
| 39 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.71159111 |
| 40 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.69809089 |
| 41 | Legionellosis_Homo sapiens_hsa05134 | 0.67333010 |
| 42 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67221081 |
| 43 | Alzheimers disease_Homo sapiens_hsa05010 | 0.65539858 |
| 44 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.65188397 |
| 45 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.64053206 |
| 46 | Homologous recombination_Homo sapiens_hsa03440 | 0.62774328 |
| 47 | Purine metabolism_Homo sapiens_hsa00230 | 0.61628499 |
| 48 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.58950810 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.57673716 |
| 50 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.57306656 |
| 51 | Base excision repair_Homo sapiens_hsa03410 | 0.54610479 |
| 52 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.53738021 |
| 53 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.50912212 |
| 54 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.50381126 |
| 55 | Olfactory transduction_Homo sapiens_hsa04740 | 0.50031258 |
| 56 | Salivary secretion_Homo sapiens_hsa04970 | 0.48051191 |
| 57 | Phagosome_Homo sapiens_hsa04145 | 0.46235314 |
| 58 | Mismatch repair_Homo sapiens_hsa03430 | 0.45611757 |
| 59 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.43263445 |
| 60 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.42565230 |
| 61 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.41737238 |
| 62 | Apoptosis_Homo sapiens_hsa04210 | 0.40188575 |
| 63 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.39418427 |
| 64 | Carbon metabolism_Homo sapiens_hsa01200 | 0.37719884 |
| 65 | Other glycan degradation_Homo sapiens_hsa00511 | 0.36530826 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.36170943 |
| 67 | Malaria_Homo sapiens_hsa05144 | 0.33475384 |
| 68 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.31559076 |
| 69 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.31445821 |
| 70 | Peroxisome_Homo sapiens_hsa04146 | 0.31345689 |
| 71 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.31147645 |
| 72 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.30985396 |
| 73 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.30079372 |
| 74 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.28147968 |
| 75 | Huntingtons disease_Homo sapiens_hsa05016 | 0.28052994 |
| 76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.26953868 |
| 77 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.26230374 |
| 78 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.26063805 |
| 79 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.25973862 |
| 80 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.24770449 |
| 81 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.24500830 |
| 82 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.24399987 |
| 83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.24347290 |
| 84 | Pertussis_Homo sapiens_hsa05133 | 0.23899081 |
| 85 | RNA degradation_Homo sapiens_hsa03018 | 0.23665889 |
| 86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.22135224 |
| 87 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.20161323 |
| 88 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.18300218 |
| 89 | Metabolic pathways_Homo sapiens_hsa01100 | 0.17888448 |
| 90 | HTLV-I infection_Homo sapiens_hsa05166 | 0.17513911 |
| 91 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.17375111 |
| 92 | Lysosome_Homo sapiens_hsa04142 | 0.16577532 |
| 93 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.14866706 |
| 94 | RNA polymerase_Homo sapiens_hsa03020 | 0.13989303 |
| 95 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.13688273 |
| 96 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.13092463 |
| 97 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.12551953 |
| 98 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.12085320 |
| 99 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.11785195 |
| 100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.10763106 |

